This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
bladder-cancer
Bladder Cancer
Urothelial carcinoma of the bladder; FGFR3 mutations in ~25-35% and TERT promoter mutations in ~75%; PD-L1 expression guides immunotherapy. BCG is standard for non-muscle-invasive disease; enfortumab vedotin + pembrolizumab is first-line for metastatic urothelial carcinoma.
Entry Metadata
| Field | Value |
|---|---|
| ID | bladder-cancer |
| Name | Bladder Cancer |
| Status | draft |
| Last reviewed | 2026-06-06 |
| Atlas | 01-human |
| Scale | 07-system |
Cross-Atlas Connections
connects-toFgfr
connects-toPd 1
connects-toTert
connects-toRb1
connects-toP53
connects-toLynch Syndrome
connects-toArid1A
connects-toKidney
connects-toT Cytotoxic Cell
connects-toCervical Cancer
connects-toProstate Cancer
connects-toRenal System
connects-toImmune System
connects-toRenal Cell Carcinoma
connects-toNsclc
connects-toMacrophage
connects-toSmooth Muscle Cell
connects-toHer2
connects-toVegf
connects-toPhoton
connects-toCdkn2A
connects-toNsclc
connects-toTuberculosis
connects-toCarbon
connects-toDendritic Cell
connects-toEgfr
connects-toNatural Killer Cell
connects-toRegulatory T Cell
connects-toNitrogen
connects-toNf Kb
connects-toNeutrophil
connects-toIron
connects-toLung
connects-toFibroblast
connects-toFibrosis
connects-toEndothelial Cell
connects-toLiver
connects-toElectron
connects-toBone Marrow
connects-toLarge Intestine
connects-toErythrocyte
connects-toAntibody
connects-toNeuron
connects-toMycobacterium Tuberculosis
connects-toReproductive System
connects-toPlatelet
connects-toPik3Ca
connects-toB Cell
connects-toHnscc
connects-toCopd
connects-toColorectal Cancer
connects-toGut Microbiome
connects-toStat3
connects-toVenous Thromboembolism
connects-toSepsis
connects-toIron Deficiency Anemia
connects-toCkd
connects-toMajor Depressive Disorder
connects-toNeuropathic Pain
connects-toAnemia Of Chronic Disease
connects-toAspergillus Fumigatus
connects-toWound Healing
connects-toDigestive System
connects-toGeneralized Anxiety Disorder
connects-toLymphatic System
connects-toMusculoskeletal System
connects-toNervous System
connects-toRespiratory System
connects-toCardiovascular System
connects-toIntegumentary System
connects-toCheckpoint Inhibitors
connects-toTargeted Therapy
connects-toCancer Chemotherapy
connects-toEndometrial Cancer
connects-toCholangiocarcinoma
connects-toCortical Bone
connects-toAlveolus
connects-toGerminal Center
connects-toPancreatic Cancer
connects-toAnca Vasculitis
connects-toType 2 Diabetes
connects-toHepatic Lobule
connects-toSclc
connects-toKras
connects-toEzh2
connects-toAkt
connects-toCyclin D1
connects-toHif 1Alpha
connects-toMyc
connects-toMtor
connects-toCcl2
connects-toTlr4
connects-toCgas Sting
connects-toCxcl12
connects-toIfn Gamma
connects-toCaspase 3
connects-toCdh1
connects-toErk1 2
connects-toE2F1
connects-toPten
connects-toMyd88
connects-toNfe2L2
connects-toTgf Beta
connects-toWnt Beta Catenin
connects-toJak1 2
connects-toGalectin 3
connects-toStat1
connects-toPerforin
connects-toCdk4 6
connects-toFoxo
connects-toSmad4
connects-toS100A8 A9
connects-toGsk 3B
connects-toMdm2
connects-toSrc Kinase
connects-toAmpk
connects-toAutophagy
connects-toCcr5
connects-toDnmt3A
connects-toIl 1B
connects-toIl 6
connects-toIl 33
connects-toIl 17A
connects-toComplement C3
connects-toMhc Class Ii
connects-toIl 2
connects-toAxl Receptor
connects-toHemoglobin
connects-toXanthine Oxidase
connects-toIl 10
connects-toNitric Oxide
connects-toProstaglandins
connects-toTroponin Complex
connects-toIl 4
connects-toIl 13
connects-toTuberculosis
connects-toT Helper Cell
connects-toLeptin
connects-toAdiponectin
connects-toResistin
connects-toKidney
connects-toDendritic Cell
connects-toType I Interferon
connects-toIl 12
connects-toIl 5
connects-toIl 23
connects-toIge
connects-toPlasma Cell
connects-toMast Cell
connects-toC5Ar1
connects-toComplement C5
connects-toFactor H
connects-toOsteopontin
connects-toTransferrin
connects-toTslp
connects-toBradykinin
connects-toErythropoietin
connects-toHistamine
connects-toMelatonin
connects-toTestosterone
connects-toProlactin
connects-toOxytocin
connects-toVasopressin
connects-toSerotonin
connects-toSelenium
connects-toIodine
connects-toSodium
connects-toPotassium
connects-toCalcium
connects-toMagnesium
connects-toCopper
connects-toZinc
connects-toChloride
connects-toHydrogen
connects-toOxygen
connects-toGlp 1
connects-toAngiotensin Ii
connects-toRankl
connects-toFibronectin
connects-toNotch
connects-toIgf 1
connects-toActivin A
connects-toCgrp
connects-toCalcitonin
connects-toSubstance P
connects-toInsulin Receptor
connects-toAldosterone
connects-toAndrogen Receptor
connects-toNorepinephrine
connects-toAdrenomedullin
connects-toBdnf
connects-toEpinephrine
connects-toRenin
Sources
- Bellmunt J, de Wit R, Vaughn DJ, et al. Pembrolizumab as second-line therapy for advanced urothelial carcinoma. N Engl J Med. 2017;376(11):1015-1026. · PubMed 28212060
- Powles T, Valderrama BP, Gupta S, et al. Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer. N Engl J Med. 2024;390(10):875-888. · PubMed 38261487
- Loriot Y, Necchi A, Park SH, et al. Erdafitinib in locally advanced or metastatic urothelial carcinoma. N Engl J Med. 2019;381(4):338-348. · PubMed 31340094